I'm downgrading Hims & Hers Health stock to a hold amid severe regulatory and legal headwinds, which erase (or pause) the GLP-1-driven bull case. GLP-1 compounding loophole closure, FDA/DOJ scrutiny, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results